{"protocolSection": {"identificationModule": {"nctId": "NCT03001674", "orgStudyIdInfo": {"id": "IABP_Hemodynamics"}, "organization": {"fullName": "Tufts Medical Center", "class": "OTHER"}, "briefTitle": "Clinical Hemodynamic Study of Balloon Counterpulsation in Advanced Heart Failure", "officialTitle": "Clinical Hemodynamic Study of Balloon Counterpulsation in Advanced Heart Failure"}, "statusModule": {"statusVerifiedDate": "2017-04", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2014-12"}, "primaryCompletionDateStruct": {"date": "2015-12", "type": "ACTUAL"}, "completionDateStruct": {"date": "2015-12", "type": "ACTUAL"}, "studyFirstSubmitDate": "2014-03-27", "studyFirstSubmitQcDate": "2016-12-20", "studyFirstPostDateStruct": {"date": "2016-12-23", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2017-04-25", "resultsFirstSubmitQcDate": "2017-04-25", "resultsFirstPostDateStruct": {"date": "2017-05-31", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2017-04-25", "lastUpdatePostDateStruct": {"date": "2017-05-31", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Tufts Medical Center", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "The primary objective of this study is to develop normative hemodynamic data (means and standard deviations) for the intra-aortic balloon pump (IABP) using pressure-volume loop and 3D-echocardiographic analyses."}, "conditionsModule": {"conditions": ["Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NON_RANDOMIZED", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "DIAGNOSTIC", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 15, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "IABP recipient", "type": "EXPERIMENTAL", "description": "Referred for clinically indicated right heart catheterization with intervention of IABP placement prior to LVAD surgery.", "interventionNames": ["Device: Conductance catheterization"]}, {"label": "Control", "type": "EXPERIMENTAL", "description": "Control subjects undergoing left heart catheterization with an LV ejection fraction \\> 50%, and without a history of heart failure symptoms who did not receive IABP therapy were enrolled.", "interventionNames": ["Device: Conductance catheterization"]}], "interventions": [{"type": "DEVICE", "name": "Conductance catheterization", "description": "CD Leycom Conductance Catheter", "armGroupLabels": ["Control", "IABP recipient"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Impact of Intra-aortic Balloon Pump Activation on Left Ventricular Stroke Work.", "description": "We will be measuring left ventricular stroke work using a conductance catheter before and immediately after activation of an intra-aortic balloon pump (IABP). Left ventricular stroke work is quantified as the product of left ventricular pressure and volume. Conductance catheters are the primary method available for clinical measurement of left ventricular volume and pressure.", "timeFrame": "24 hours"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Male or females between 18-75 years of age\n* NYHA Class III-IV heart failure at the time of MEGA deployment\n* Stage C-D systolic heart failure\n* Non-ischemic cardiomyopathy\n* Preserved right ventricular function defined by 2D-echocardiography\n* Clinically indicated left and right heart catheterization and MEGA-IABP placement\n* Clinically indicated MEGA-IABP support for 12 hours minimum\n\nExclusion Criteria:\n\n* Ischemic cardiomyopathy\n* Active myocardial ischemia or acute coronary syndrome\n* Severe peripheral vascular disease\n* Severe aortic or mitral valve insufficiency\n* Severe aortic or mitral valve stenosis\n* Right ventricular failure\n* Inability to tolerate left and right heart catheterization\n* Severe hemodynamic instability defined as a systolic BP \\<80mmHg despite vasopressor/inotropic support\n* Sustained ventricular tachycardia (\\>10 beats) within 24 hours and/or ventricular fibrillation within 24 hours\n* Pacemaker dependent rhythm\n* Left ventricular thrombus\n* Rapid atrial fibrillation (HR\\>120 bpm)\n* Unable to provide informed consent\n* Pregnancy", "healthyVolunteers": true, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "75 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Navin Kapur, MD", "affiliation": "Tufts Medical Center", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Tufts Medical Center", "city": "Boston", "state": "Massachusetts", "zip": "02111", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}]}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "10 patients with advanced HF from 2014 to 2015 at Tufts Medical Center referred for clinically indicated RHC and IABP placement prior to LVAD surgery. Five control subjects undergoing left heart catheterization with an LV ejection fraction \\> 50%, and without a history of heart failure symptoms who did not receive IABP therapy were enrolled.", "groups": [{"id": "FG000", "title": "IABP Recipient", "description": "Prospective, double-arm, pilot study.\n\nConductance catheterization: CD Leycom Conductance Catheter"}, {"id": "FG001", "title": "Control Group", "description": "Control subjects undergoing left heart catheterization with an LV ejection fraction \\> 50%, and without a history of heart failure symptoms who did not receive IABP therapy were enrolled."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "10"}, {"groupId": "FG001", "numSubjects": "5"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "10"}, {"groupId": "FG001", "numSubjects": "5"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "IABP Recipient", "description": "Conductance catheterization: CD Leycom Conductance Catheter"}, {"id": "BG001", "title": "Control", "description": "Conductance catheterization: CD Leycom Conductance Catheter"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "10"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "15"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "57", "spread": "14"}, {"groupId": "BG001", "value": "54", "spread": "13"}, {"groupId": "BG002", "value": "56", "spread": "13"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "4"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "8"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "11"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "10"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "15"}]}]}]}, {"title": "Body Surface Area (BSA)", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "m^2", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "2.07", "spread": "0.33"}, {"groupId": "BG001", "value": "2.22", "spread": "0.15"}, {"groupId": "BG002", "value": "2.12", "spread": "0.28"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Impact of Intra-aortic Balloon Pump Activation on Left Ventricular Stroke Work.", "description": "We will be measuring left ventricular stroke work using a conductance catheter before and immediately after activation of an intra-aortic balloon pump (IABP). Left ventricular stroke work is quantified as the product of left ventricular pressure and volume. Conductance catheters are the primary method available for clinical measurement of left ventricular volume and pressure.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg-mL", "timeFrame": "24 hours", "groups": [{"id": "OG000", "title": "IABP Recipient", "description": "Referred for clinically indicated right heart catheterization with intervention of IABP placement prior to LVAD surgery.\n\nConductance catheterization: CD Leycom Conductance Catheter"}, {"id": "OG001", "title": "Control", "description": "Control subjects undergoing left heart catheterization with an LV ejection fraction \\> 50%, and without a history of heart failure symptoms who did not receive IABP therapy were enrolled.\n\nConductance catheterization: CD Leycom Conductance Catheter"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "5"}]}], "classes": [{"title": "Stroke work without IABP", "categories": [{"measurements": [{"groupId": "OG000", "value": "939", "spread": "302"}, {"groupId": "OG001", "value": "5628", "spread": "2866"}]}]}, {"title": "Stroke work with IABP", "categories": [{"measurements": [{"groupId": "OG000", "value": "667", "spread": "210"}, {"groupId": "OG001", "value": "NA", "spread": "NA", "comment": "Number value for control patients (who did not receive an IABP) should be 'not applicable'"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "IABP Recipient", "description": "Prospective, double-arm, pilot study.\n\nConductance catheterization: CD Leycom Conductance Catheter", "deathsNumAffected": 0, "deathsNumAtRisk": 10, "seriousNumAffected": 0, "seriousNumAtRisk": 10, "otherNumAffected": 0, "otherNumAtRisk": 10}, {"id": "EG001", "title": "Control Group", "description": "Control subjects undergoing left heart catheterization with an LV ejection fraction \\> 50%, and without a history of heart failure symptoms who did not receive IABP therapy were enrolled.", "deathsNumAffected": 0, "deathsNumAtRisk": 5, "seriousNumAffected": 0, "seriousNumAtRisk": 5, "otherNumAffected": 0, "otherNumAtRisk": 5}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "Small number of patients studied. Non-randomized study."}, "certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Dr. Navin Kapur", "organization": "Tufts Medical Center", "email": "nkapur@tuftsmedicalcenter.org", "phone": "617 636 0720"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}